CareDx (CDNA) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
CareDx insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 7 sold $13.3M of CDNA stock on the open market.
Get emailed when insiders cluster-buy stocks like CDNA
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
CDNA insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $9.4M | 9 |
| Q2 2026 | — | 0 | $3.0M | 10 |
| Q1 2026 | — | 0 | $717K | 4 |
| Q4 2025 | — | 0 | $182K | 3 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 CareDx, Inc. insiders reported open-market purchases totaling $0, while 7 insiders reported sales totaling $13.3M. 22 of 26 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 6SEC | Michael GoldbergDirector | Sell | 44,70061,738 held (−42%) | $47.06 | $2.1M | +35.3% | — |
| Aug 6SEC | George BickerstaffDirector | Sell | 20,000134,061 held (−13%) | $46.29 | $926K | +37.5% | — |
| Aug 6SEC | Christine CournoyerDirector | Sell Plan | 16,00042,943 held (−27%) | $46.94 | $751K | +35.6% | — |
| Aug 6SEC | Jeffrey Adam NovackGeneral Counsel | Sell Plan | 2,188106,575 held (−2%) | $46.15 | $101K | +38.0% | — |
| Aug 6SEC | Jeffrey Adam NovackGeneral Counsel | Sell Plan | 500106,075 held (−0%) | $46.75 | $23K | +36.2% | — |
| Jul 17SEC | John Walter Hanna Jr.CEO, President | Sell Plan | 68,000653,448 held (−9%) | $39.01 | $2.7M | +63.2% | — |
| Jul 17SEC | John Walter Hanna Jr.CEO, President | Sell Plan | 50,000721,448 held (−6%) | $36.11 | $1.8M | +76.3% | — |
| Jul 17SEC | Hannah ValantineDirector | Sell Plan | 28,67936,786 held (−44%) | $36.14 | $1.0M | +76.2% | — |
| Jul 17SEC | Hannah ValantineDirector | Sell Plan | 10036,686 held (−0%) | $36.55 | $4K | +74.2% | — |
| Jun 30SEC | John Walter Hanna Jr.CEO, President | Sell Plan | 39,900661,959 held (−6%) | $29.24 | $1.2M | +117.7% | — |
| Jun 30SEC | John Walter Hanna Jr.CEO, President | Sell Plan | 100661,959 held (−0%) | $29.00 | $3K | +119.6% | — |
| Jun 17SEC | John Walter Hanna Jr.CEO, President | Sell Plan | 17,683631,959 held (−3%) | $24.03 | $425K | +165.0% | — |
| Jun 16SEC | Hannah ValantineDirector | Sell Plan | 12,10336,686 held (−25%) | $23.11 | $280K | +175.5% | — |
| Jun 15SEC | John Walter Hanna Jr.CEO, President | Sell Plan | 21,998649,642 held (−3%) | $24.02 | $528K | +165.1% | — |
| Jun 8SEC | John Walter Hanna Jr.CEO, President | Sell Plan | 4,835671,640 held (−1%) | $24.00 | $116K | +165.3% | — |
| May 18SEC | Arthur A TorresDirector | Sell | 6,48438,665 held (−14%) | $19.89 | $129K | +220.1% | — |
| May 18SEC | Arthur A TorresDirector | Sell | 4,08645,149 held (−8%) | $20.97 | $86K | +203.6% | — |
| May 6SEC | Jeffrey Adam NovackGeneral Counsel | Sell Plan | 2,688113,924 held (−2%) | $20.68 | $56K | +207.9% | — |
| Apr 20SEC | John Walter Hanna Jr.CEO, President | Sell Plan | 10,282676,475 held (−1%) | $21.12 | $217K | +201.5% | — |
| Feb 4SEC | Jeffrey Adam NovackGeneral Counsel | Sell Plan | 4,441125,364 held (−3%) | $20.56 | $91K | +209.7% | — |
| Jan 23SEC | John Walter Hanna Jr.CEO, President | Sell Plan | 19,280597,405 held (−3%) | $21.16 | $408K | +200.9% | — |
| Jan 23SEC | John Walter Hanna Jr.CEO, President | Sell Plan | 200616,685 held (−0%) | $21.00 | $4K | +203.2% | — |
| Jan 20SEC | John Walter Hanna Jr.CEO, President | Sell Plan | 10,156616,885 held (−2%) | $21.05 | $214K | +202.5% | — |
| Dec 5SEC | Jeffrey Adam NovackGeneral Counsel | Sell Plan | 7,00798,211 held (−7%) | $19.15 | $134K | +232.5% | — |
| Dec 5SEC | Jeffrey Adam NovackGeneral Counsel | Sell Plan | 28697,925 held (−0%) | $19.75 | $6K | +222.4% | — |
| Nov 10SEC | Jeffrey Adam NovackGeneral Counsel | Sell Plan | 2,688105,218 held (−2%) | $15.52 | $42K | +310.2% | — |
Insiders at CareDx, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| John Walter Hanna Jr.CEO, President | — | $7.5M | Jul 17, 2026 | — |
| Michael GoldbergDirector | — | $2.1M | Aug 6, 2026 | — |
| Hannah ValantineDirector | — | $1.3M | Jul 17, 2026 | — |
| George BickerstaffDirector | — | $926K | Aug 6, 2026 | — |
| Christine CournoyerDirector | — | $751K | Aug 6, 2026 | — |
| Jeffrey Adam NovackGeneral Counsel | — | $453K | Aug 6, 2026 | — |
| Arthur A TorresDirector | — | $215K | May 18, 2026 | — |
CDNA stock: common questions
Are CareDx, Inc. insiders buying CDNA stock?
In the past 12 months, 0 insiders reported open-market purchases of CDNA worth $0.
Are CareDx, Inc. insiders selling CDNA stock?
7 insiders reported sales worth $13.3M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is CDNA's 52-week range?
Over the past year CDNA has traded between $14.28 and $69.85. It last closed at $63.67 on Oct 9, 2026.